Cargando…
Role of DNA Methyl-CpG-Binding Protein MeCP2 in Rett Syndrome Pathobiology and Mechanism of Disease
Rett Syndrome (RTT) is a severe, rare, and progressive developmental disorder with patients displaying neurological regression and autism spectrum features. The affected individuals are primarily young females, and more than 95% of patients carry de novo mutation(s) in the Methyl-CpG-Binding Protein...
Autores principales: | Pejhan, Shervin, Rastegar, Mojgan |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7827577/ https://www.ncbi.nlm.nih.gov/pubmed/33429932 http://dx.doi.org/10.3390/biom11010075 |
Ejemplares similares
-
The Epigenetic Reader Methyl-CpG-Binding Protein 2 (MeCP2) Is an Emerging Oncogene in Cancer Biology
por: Nejati-Koshki, Kazem, et al.
Publicado: (2023) -
The MeCP2E1/E2-BDNF-miR132 Homeostasis Regulatory Network Is Region-Dependent in the Human Brain and Is Impaired in Rett Syndrome Patients
por: Pejhan, Shervin, et al.
Publicado: (2020) -
Methyl CpG binding protein 2 (MeCP2) enhances photodimer formation at methyl-CpG sites but suppresses dimer deamination
por: Cannistraro, Vincent J., et al.
Publicado: (2010) -
Early intervention with psychostimulants or antidepressants to increase methyl-CpG-binding protein 2 (MeCP2) expressions: A potential therapy for Rett syndrome
por: Pan, Chia-Ho, et al.
Publicado: (2012) -
MeCP2 Is an Epigenetic Factor That Links DNA Methylation with Brain Metabolism
por: Vuu, Yen My, et al.
Publicado: (2023)